Press Releases

Medical 3D Printing Plastics Market is Anticipated to Grow US$ 3.7 Bn By 2030

The global Medical 3D Printing Plastics market size is expected to reach USD 3.7 billion by 2030 and is expected to expand at a CAGR of 28.2% from 2021 to 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38638

Growth Factors

 Demand for medical 3D printing plastics is ascending at a prominent rate owing to the COVID-19 pandemic situation. The pandemic situation caused a sudden increase in demand for face mask and covers, gloves, head and shoes cover, and other medical devices. The growing aging population, increasing healthcare awareness, and the COVID-19 pandemic situation are some of the major factors driving the market for medical 3D printing plastics. The market is primarily driven by rising demand for face masks, head and shoe covers, surgical masks and gloves, personal protective gowns, and various other products in tackling the COVID-19 pandemic situation.

Report Coverage

Report Scope Details
Market Size USD 3.7 billion by 2030
Growth Rate CAGR of 28.2% From 2021 to 2030
Base Year 2021
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Type, Form
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned 3D Systems, Inc.; Apium Additive Technologies GmbH; Arkema; DSM; ENVISIONTEC, INC.; Evonik Industries AG; SABIC; Solvay; Stratasys Ltd; Victrex plc.

Report Highlights

In terms of revenue, photopolymer accounted the market with a share of 50.9% in 2020. This is attributed to the high demand for catheters, surgical masks, medical filters, drug delivery systems, and tissue engineering and cell encapsulation systems. Photopolymer possesses excellent thermo-mechanical properties, such as resistance to chemicals and high thermal accuracy, and it changes its phase from solid to liquid under ultraviolet light. These properties make it suitable for medical 3D printing applications.

ABS is widely used in the medical 3D printing process using a fused deposition modeling process. It is used to produce medical equipment, compressors, and various other products. ABS possesses properties, such a higher strength, flexibility, and durability.

In terms of revenue, filament accounted the market with a share of 78.1% in 2020. Increasing utilization of medical 3D printing plastics to produce a wide range of healthcare products, such as specialized surgical tools in reusable and single-use medical devices, is boosting the segment growth. Medical 3D printing plastics such as ABS, PEEK, PETG, photopolymer, polyamide, polylactic acid are primarily used in filament form in the 3D printing process.

North America accounted the market for medical 3D printing plastics with a volume share of 46.9% in 2020. This is attributed to various factors such as rising awareness among the consumers, increasing healthcare spending, and growing demand for disposable plastics.

Asia Pacific is projecetd to expand at the fastest CAGR of 29.3% in terms of volume from 2021 to 2030. The regional market is majorly driven by growing demand from developing economies, such as China, India, and Malaysia.

Key Players

  • 3D Systems, Inc.
  • Apium Additive Technologies GmbH
  • Arkema
  • DSM
  • ENVISIONTEC, INC.
  • Evonik Industries AG
  • SABIC
  • Solvay
  • Stratasys Ltd.
  • Victrex plc.

Market Segmentation

  • Type
    • ABS
    • PEEK
    • PETG
    • Photopolymer
    • Polyamide
    • Polylactic Acid
  • Form
    • Filament
    • Powder
    • Ink
  • Regional
    • North America
      • The U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • The U.K.
      • France
      • Italy
    • Asia Pacific
      • China
      • India
      • Japan
    • Central & South America
      • Brazil
      • Argentina
    • Middle East & Africa
      • Saudi Arabia
      • South Africa

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38638

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Medical 3D Printing Plastics Market, By Type

7.1.  Medical 3D Printing Plastics Market, by Type, 2021-2030

7.1.1.    ABS

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    PEEK

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    PETG

7.1.3.1.        Market Revenue and Forecast (2017-2030)

7.1.4.    Photopolymer

7.1.4.1.        Market Revenue and Forecast (2017-2030)

7.1.5.    Polyamide

7.1.5.1.        Market Revenue and Forecast (2017-2030)

7.1.6.    Polylactic Acid

7.1.6.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Medical 3D Printing Plastics Market, By Form

8.1.  Medical 3D Printing Plastics Market, by Form, 2021-2030

8.1.1.    Filament

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Powder

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Ink

8.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Medical 3D Printing Plastics Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Type (2017-2030)

9.1.2.    Market Revenue and Forecast, by Form (2017-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Type (2017-2030)

9.1.3.2.        Market Revenue and Forecast, by Form (2017-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Type (2017-2030)

9.1.4.2.        Market Revenue and Forecast, by Form (2017-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Type (2017-2030)

9.2.2.    Market Revenue and Forecast, by Form (2017-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Type (2017-2030)

9.2.3.2.        Market Revenue and Forecast, by Form (2017-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Type (2017-2030)

9.2.4.2.        Market Revenue and Forecast, by Form (2017-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Type (2017-2030)

9.2.5.2.        Market Revenue and Forecast, by Form (2017-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Type (2017-2030)

9.2.6.2.        Market Revenue and Forecast, by Form (2017-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Type (2017-2030)

9.3.2.    Market Revenue and Forecast, by Form (2017-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Type (2017-2030)

9.3.3.2.        Market Revenue and Forecast, by Form (2017-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Type (2017-2030)

9.3.4.2.        Market Revenue and Forecast, by Form (2017-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Type (2017-2030)

9.3.5.2.        Market Revenue and Forecast, by Form (2017-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Type (2017-2030)

9.3.6.2.        Market Revenue and Forecast, by Form (2017-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Type (2017-2030)

9.4.2.    Market Revenue and Forecast, by Form (2017-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Type (2017-2030)

9.4.3.2.        Market Revenue and Forecast, by Form (2017-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Type (2017-2030)

9.4.4.2.        Market Revenue and Forecast, by Form (2017-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Type (2017-2030)

9.4.5.2.        Market Revenue and Forecast, by Form (2017-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Type (2017-2030)

9.4.6.2.        Market Revenue and Forecast, by Form (2017-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Type (2017-2030)

9.5.2.    Market Revenue and Forecast, by Form (2017-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Type (2017-2030)

9.5.3.2.        Market Revenue and Forecast, by Form (2017-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Type (2017-2030)

9.5.4.2.        Market Revenue and Forecast, by Form (2017-2030)

Chapter 10.  Company Profiles

10.1.              3D Systems, Inc

10.1.1.  Company Overview

10.1.2.  Type Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Apium Additive Technologies GmbH

10.2.1.  Company Overview

10.2.2.  Type Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Arkema

10.3.1.  Company Overview

10.3.2.  Type Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              DSM

10.4.1.  Company Overview

10.4.2.  Type Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              ENVISIONTEC, INC.

10.5.1.  Company Overview

10.5.2.  Type Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              Evonik Industries AG

10.6.1.  Company Overview

10.6.2.  Type Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              SABIC

10.7.1.  Company Overview

10.7.2.  Type Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Solvay

10.8.1.  Company Overview

10.8.2.  Type Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              Stratasys Ltd.

10.9.1.  Company Overview

10.9.2.  Type Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.           Victrex plc.

10.10.1.               Company Overview

10.10.2.               Type Offerings

10.10.3.               Financial Performance

10.10.4.               Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

12.2.              Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38638

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com

 

Show More

Related Articles

Back to top button